All doxorubicin articles

  • Low-Res_researchers-group
    News

    Cancer drug repurposed to treat drug-resistant herpes

    2026-03-24T14:55:00Z

    Researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. A digital tool that combs through chemical compounds and flags those that may be effective against herpes infections, identified doxorubicin, a known anticancer drug.